Home › Funds › Dodge & Cox › GILD

Dodge & Cox position in GILD

GILEAD SCIENCES INC · Health Care

Dodge & Cox reported holding 21,800,593 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.25B, representing 1.74% of its reported portfolio and ranking #17 among its reported holdings. Dodge & Cox has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)21.80M sh
Reported value held$3.25B
Portfolio Weight1.74%
First reportedQ3 2021
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Dodge & Cox's GILD position evolved

Dodge & Cox first disclosed a stake in GILD in Q3 2021 at 37,266,692 shares (US$2.60B). The position peaked in Q1 2025 at 32,694,791 shares, worth US$3.66B. Across 21 filings, Dodge & Cox increased the stake 0 time(s), trimmed it 13 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 21,800,593 shares valued at US$3.25B — a reduction of -1,876,974 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2021 37.27M $2.60B New
Q4 2021 37.17M $2.70B Hold
Q1 2022 37.03M $2.20B Hold
Q2 2022 36.97M $2.28B Hold
Q3 2022 36.37M $2.24B Reduce
Q4 2022 35.89M $3.08B Reduce
Q1 2023 34.70M $2.88B Reduce
Q2 2023 33.98M $2.62B Reduce
Q3 2023 33.53M $2.51B Reduce
Q4 2023 33.30M $2.70B Reduce
Q1 2024 33.17M $2.43B Hold
Q2 2024 33.12M $2.27B Hold
Q3 2024 33.05M $2.77B Hold
Q4 2024 32.95M $3.04B Hold
Q1 2025 32.69M $3.66B Reduce
Q2 2025 30.82M $3.42B Reduce
Q3 2025 30.13M $3.34B Reduce
Q4 2025 26.28M $3.23B Reduce
Q1 2026 24.25M $3.38B Reduce
Q2 2026 23.68M $2.99B Reduce
Q3 2026 21.80M $3.25B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Dodge & Cox held GILD?

Dodge & Cox has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Dodge & Cox's current position in GILD?

As of Q3 2026, Dodge & Cox holds 21.80M shares of GILD (GILEAD SCIENCES INC), valued at $3.25B, representing 1.74% of its reported portfolio and ranking #17.

Has Dodge & Cox been buying or selling GILD?

In the latest 13F filing (Q3 2026), Dodge & Cox reduced its position in GILD. The position peaked in Q1 2025 at 32.69M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.